KEGG   PATHWAY: tpai04310
Entry
tpai04310                   Pathway                                
Name
Wnt signaling pathway - Tympanuchus pallidicinctus (lesser prairie-chicken)
Description
Wnt proteins are secreted morphogens that are required for basic developmental processes, such as cell-fate specification, progenitor-cell proliferation and the control of asymmetric cell division, in many different species and organs. There are at least three different Wnt pathways: the canonical pathway, the planar cell polarity (PCP) pathway and the Wnt/Ca2+ pathway. In the canonical Wnt pathway, the major effect of Wnt ligand binding to its receptor is the stabilization of cytoplasmic beta-catenin through inhibition of the bea-catenin degradation complex. Beta-catenin is then free to enter the nucleus and activate Wnt-regulated genes through its interaction with TCF (T-cell factor) family transcription factors and concomitant recruitment of coactivators. Planar cell polarity (PCP) signaling leads to the activation of the small GTPases RHOA (RAS homologue gene-family member A) and RAC1, which activate the stress kinase JNK (Jun N-terminal kinase) and ROCK (RHO-associated coiled-coil-containing protein kinase 1) and leads to remodelling of the cytoskeleton and changes in cell adhesion and motility. WNT-Ca2+ signalling is mediated through G proteins and phospholipases and leads to transient increases in cytoplasmic free calcium that subsequently activate the kinase PKC (protein kinase C) and CAMKII (calcium calmodulin mediated kinase II) and the phosphatase calcineurin.
Class
Environmental Information Processing; Signal transduction
Pathway map
tpai04310  Wnt signaling pathway
tpai04310

Other DBs
GO: 0016055
Organism
Tympanuchus pallidicinctus (lesser prairie-chicken) [GN:tpai]
Gene
128071831  TBL1X; F-box-like/WD repeat-containing protein TBL1X [KO:K04508]
128072414  GSK3B; glycogen synthase kinase-3 beta [KO:K03083] [EC:2.7.11.26]
128072417  CACYBP; calcyclin-binding protein [KO:K04507]
128072448  JUN; transcription factor Jun [KO:K04448]
128072517  VANGL1; vang-like protein 1 [KO:K04510]
128072737  ROR1; inactive tyrosine-protein kinase transmembrane receptor ROR1 isoform X1 [KO:K05122] [EC:2.7.10.1]
128072854  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
128073135  WNT5B; protein Wnt-5b [KO:K00444]
128073176  EP300; histone acetyltransferase p300 isoform X1 [KO:K04498] [EC:2.3.1.48]
128073523  CSNK1E; casein kinase I [KO:K08960] [EC:2.7.11.1]
128073596  CBY1; protein chibby homolog 1 [KO:K23402]
128073610  RBX1; E3 ubiquitin-protein ligase RBX1 [KO:K03868] [EC:2.3.2.32]
128073655  RAC2; ras-related C3 botulinum toxin substrate 2 isoform X1 [KO:K07860]
128073677  [KO:K04497]
128073712  WIF1; wnt inhibitory factor 1 [KO:K01691]
128073736  WNT16; protein Wnt-16 [KO:K01558]
128073787  PRICKLE1; prickle-like protein 1 [KO:K04511]
128073794  LGR5; leucine-rich repeat-containing G-protein coupled receptor 5 [KO:K04308]
128073808  WNT2; protein Wnt-2 [KO:K00182]
128074252  [KO:K04501]
128074265  FZD4; frizzled-4 [KO:K02354]
128074819  MMP7; matrilysin [KO:K01397] [EC:3.4.24.23]
128074905  WNT11; protein Wnt-11 isoform X1 [KO:K01384]
128075275  TLE3; transducin-like enhancer protein 3 isoform X1 [KO:K04497]
128075392  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
128075634  SMAD3; mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605]
128075775  MAP3K7; mitogen-activated protein kinase kinase kinase 7 isoform X1 [KO:K04427] [EC:2.7.11.25]
128075820  GPC4; glypican-4 [KO:K08110]
128076080  [KO:K01384]
128076919  WNT10A; protein Wnt-10a [KO:K01357]
128077166  WNT6; protein Wnt-6 isoform X1 [KO:K00445]
128077249  FRZB; secreted frizzled-related protein 3 [KO:K25481]
128077263  FZD5; frizzled-5 [KO:K02375]
128077298  FZD7; frizzled-7 [KO:K02432]
128077484  BTRC; F-box/WD repeat-containing protein 1A isoform X1 [KO:K03362]
128077531  CTBP2; C-terminal-binding protein 2 isoform X1 [KO:K04496] [EC:1.1.1.428]
128077713  LZTS2; leucine zipper putative tumor suppressor 2 [KO:K26471]
128077836  SFRP5; secreted frizzled-related protein 5 [KO:K02222]
128077849  WNT8B; protein Wnt-8b [KO:K00714]
128077851  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
128077933  DKK1; dickkopf-related protein 1 [KO:K02165]
128077983  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
128078068  RSPO3; R-spondin-3 [KO:K23098]
128078110  SIRT1; NAD-dependent protein deacetylase sirtuin-1 [KO:K11411] [EC:2.3.1.286]
128078201  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
128078211  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
128078459  PRICKLE2; prickle-like protein 2 isoform X1 [KO:K04511]
128078518  RUVBL1; ruvB-like 1 [KO:K04499] [EC:5.6.2.4]
128078522  WNT5A; protein Wnt-5a isoform X1 [KO:K00444]
128078543  WNT7A; protein Wnt-7a [KO:K00572]
128078635  PPP3R1; calcineurin subunit B type 1 [KO:K06268]
128078777  RHOA; transforming protein RhoA [KO:K04513]
128078939  CREBBP; CREB-binding protein isoform X1 [KO:K04498] [EC:2.3.1.48]
128078963  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
128079308  RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
128079319  AXIN1; axin-1 [KO:K02157]
128079832  CTBP1; C-terminal-binding protein 1 isoform X1 [KO:K04496] [EC:1.1.1.428]
128079862  CXXC4; CXXC-type zinc finger protein 4 [KO:K03344]
128079870  PPP3CA; protein phosphatase 3 catalytic subunit alpha isoform X1 [KO:K04348] [EC:3.1.3.16]
128079887  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515] [EC:2.7.11.17]
128079966  MAPK10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
128079992  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
128079996  DKK2; dickkopf-related protein 2 isoform X1 [KO:K02165]
128080697  DAAM2; disheveled-associated activator of morphogenesis 2 isoform X1 [KO:K04512]
128080796  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X1 [KO:K17332]
128080960  CSNK2A1; casein kinase II subunit alpha [KO:K03097] [EC:2.7.11.1]
128080961  RSPO4; R-spondin-4 isoform X1 [KO:K23099]
128081135  APCDD1L; protein APCDD1-like [KO:K25812]
128081464  CSNK1A1; casein kinase I isoform X1 [KO:K08957] [EC:2.7.11.1]
128081548  FBXW11; F-box/WD repeat-containing protein 11 isoform X1 [KO:K03362]
128081602  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
128081894  SIAH1; E3 ubiquitin-protein ligase SIAH1 [KO:K04506] [EC:2.3.2.27]
128081918  NFATC3; nuclear factor of activated T-cells, cytoplasmic 3 isoform X1 [KO:K17333]
128081959  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353]
128082131  RYK; tyrosine-protein kinase RYK isoform X1 [KO:K05128] [EC:2.7.10.1]
128082134  SENP2; sentrin-specific protease 2 [KO:K03345] [EC:3.4.22.68]
128082228  NKD1; protein naked cuticle homolog 1 [KO:K03213]
128082425  TBL1XR1; F-box-like/WD repeat-containing protein TBL1XR1 [KO:K04508]
128082470  CSNK2A2; casein kinase II subunit alpha' isoform X1 [KO:K03097] [EC:2.7.11.1]
128083107  AXIN2; axin-2 isoform X1 [KO:K04385]
128083108  PRKCA; protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
128083197  NOTUM; palmitoleoyl-protein carboxylesterase NOTUM [KO:K19882] [EC:3.1.1.98]
128083202  RAC3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
128083330  SERPINF1; pigment epithelium-derived factor [KO:K19614]
128083471  RNF43; E3 ubiquitin-protein ligase RNF43 [KO:K15694] [EC:2.3.2.27]
128083614  FZD9; frizzled-9 [KO:K02842]
128083625  NLK; serine/threonine-protein kinase NLK isoform X1 [KO:K04468] [EC:2.7.11.24]
128083801  [KO:K04496] [EC:1.1.1.428]
128083871  ZNRF3; E3 ubiquitin-protein ligase ZNRF3 [KO:K16273] [EC:2.3.2.27]
128083876  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
128083947  WNT8A; protein Wnt-8a [KO:K00714]
128083971  TCF7; transcription factor 7 isoform X1 [KO:K02620]
128083975  SKP1; S-phase kinase-associated protein 1 [KO:K03094]
128084251  ROCK2; rho-associated protein kinase 2 [KO:K17388] [EC:2.7.11.1]
128084382  SFRP2; secreted frizzled-related protein 2 [KO:K02176]
128084427  LRP6; low-density lipoprotein receptor-related protein 6 isoform X1 [KO:K03068]
128084452  WNT7B; protein Wnt-7b [KO:K00572]
128084476  CCND2; G1/S-specific cyclin-D2 isoform X1 [KO:K10151]
128084735  FZD10; frizzled-10 [KO:K02842]
128084851  CTNNBIP1; beta-catenin-interacting protein 1 [KO:K04493]
128085073  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
128085111  WNT4; protein Wnt-4 isoform X1 [KO:K00408]
128085115  FZD3; frizzled-3 isoform X1 [KO:K02329]
128085292  LGR4; leucine-rich repeat-containing G-protein coupled receptor 4 [KO:K04309]
128085458  FZD8; frizzled-8 [KO:K02375]
128085979  CCDC88C; protein Daple isoform X1 [KO:K25811]
128086077  CTNNB1; catenin beta-1 isoform X1 [KO:K02105]
128086335  FZD1; frizzled-1 [KO:K02432]
128086356  LRP5; low-density lipoprotein receptor-related protein 5 isoform X1 [KO:K03068]
128086434  WNT9A; protein Wnt-9a [KO:K01064]
128086435  WNT3A; protein Wnt-3a [KO:K00312]
128086467  BAMBI; BMP and activin membrane-bound inhibitor homolog isoform X1 [KO:K10162]
128086508  CCND1; G1/S-specific cyclin-D1 isoform X1 [KO:K04503]
128086570  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
128086668  PSEN1; presenilin-1 isoform X1 [KO:K04505] [EC:3.4.23.-]
128086829  SFRP4; secreted frizzled-related protein 4 [KO:K02185]
128086840  DAAM1; LOW QUALITY PROTEIN: disheveled-associated activator of morphogenesis 1 [KO:K04512]
128087418  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
128087775  CUL1; cullin-1 isoform X1 [KO:K03347]
128087895  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X1 [KO:K04446]
128087990  PPARD; peroxisome proliferator-activated receptor delta isoform X1 [KO:K04504]
128087997  CCND3; G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
128088015  WNT2B; protein Wnt-2b [KO:K00182]
128088356  RSPO1; R-spondin-1 isoform X1 [KO:K19471]
128088743  WNT3; proto-oncogene Wnt-3 [KO:K00312]
128088752  WNT9B; protein Wnt-9b [KO:K01064]
128088823  FZD2; frizzled-2 [KO:K02235]
128088929  APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
128089393  TLE1; transducin-like enhancer protein 1 isoform X1 [KO:K04497]
128089394  TLE4; transducin-like enhancer protein 4 isoform X1 [KO:K04497]
128089406  CER1; cerberus [KO:K01645]
128089479  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
128089487  MCC; colorectal mutant cancer protein isoform X1 [KO:K26734]
128089490  ROR2; tyrosine-protein kinase transmembrane receptor ROR2 [KO:K05123] [EC:2.7.10.1]
128089971  SFRP1; secreted frizzled-related protein 1 [KO:K02166]
128090046  PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
128090167  TCF7L1; transcription factor 7-like 1 isoform X1 [KO:K04490]
128090212  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
128090279  LGR6; leucine-rich repeat-containing G-protein coupled receptor 6 [KO:K08399]
128090356  [KO:K04497]
128090580  [KO:K04501]
128090650  VANGL2; vang-like protein 2 [KO:K04510]
128090702  [KO:K04495]
128090703  [KO:K04495]
128090904  APCDD1; protein APCDD1 [KO:K25812]
128091004  CTNND2; catenin delta-2 isoform X1 [KO:K23491]
128091157  INVS; inversin isoform X1 [KO:K19626]
128091221  CCN4; CCN family member 4 isoform X1 [KO:K22471]
128091360  RSPO2; R-spondin-2 isoform X1 [KO:K23097]
128091387  [KO:K03096]
128091518  FZD6; frizzled-6 [KO:K02376]
128091562  MYC; myc proto-oncogene protein [KO:K04377]
128091771  SOST; sclerostin isoform X1 [KO:K16834]
Compound
C00076  Calcium cation
Reference
  Authors
Hatsell S, Rowlands T, Hiremath M, Cowin P.
  Title
Beta-catenin and Tcfs in mammary development and cancer.
  Journal
J Mammary Gland Biol Neoplasia 8:145-58 (2003)
DOI:10.1023/A:1025944723047
Reference
  Authors
Yang Y.
  Title
Wnts and wing: Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis.
  Journal
Birth Defects Res Part C Embryo Today 69:305-17 (2003)
DOI:10.1002/bdrc.10026
Reference
  Authors
Kalderon D.
  Title
Similarities between the Hedgehog and Wnt signaling pathways.
  Journal
Trends Cell Biol 12:523-31 (2002)
DOI:10.1016/S0962-8924(02)02388-7
Reference
  Authors
Nusse R.
  Title
Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface.
  Journal
Development 130:5297-305 (2003)
DOI:10.1242/dev.00821
Reference
  Authors
Jope RS, Johnson GV.
  Title
The glamour and gloom of glycogen synthase kinase-3.
  Journal
Trends Biochem Sci 29:95-102 (2004)
DOI:10.1016/j.tibs.2003.12.004
Reference
  Authors
Veeman MT, Axelrod JD, Moon RT.
  Title
A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling.
  Journal
Dev Cell 5:367-77 (2003)
DOI:10.1016/S1534-5807(03)00266-1
Reference
  Authors
Sun TQ, Lu B, Feng JJ, Reinhard C, Jan YN, Fantl WJ, Williams LT.
  Title
PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling.
  Journal
Nat Cell Biol 3:628-36 (2001)
DOI:10.1038/35083016
Reference
  Authors
Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A, Lee E
  Title
The way Wnt works: Components and mechanism.
  Journal
Growth Factors 31:1-31 (2013)
DOI:10.3109/08977194.2012.752737
Reference
  Authors
Carethers JM
  Title
Intersection of transforming growth factor-beta and Wnt signaling pathways in colorectal cancer and metastasis.
  Journal
Gastroenterology 137:33-6 (2009)
DOI:10.1053/j.gastro.2009.05.011
Reference
  Authors
Lin Z, Gao C, Ning Y, He X, Wu W, Chen YG
  Title
The pseudoreceptor BMP and activin membrane-bound inhibitor positively modulates Wnt/beta-catenin signaling.
  Journal
J Biol Chem 283:33053-8 (2008)
DOI:10.1074/jbc.M804039200
Reference
  Authors
Niehrs C
  Title
The complex world of WNT receptor signalling.
  Journal
Nat Rev Mol Cell Biol 13:767-79 (2012)
DOI:10.1038/nrm3470
Reference
  Authors
Abou Ziki MD, Mani A
  Title
Wnt signaling, a novel pathway regulating blood pressure? State of the art review.
  Journal
Atherosclerosis 262:171-178 (2017)
DOI:10.1016/j.atherosclerosis.2017.05.001
Reference
  Authors
He Y, Ki H, Kim H, Kim K
  Title
delta-Catenin interacts with LEF-1 and negatively regulates its transcriptional activity.
  Journal
Cell Biol Int 39:954-61 (2015)
DOI:10.1002/cbin.10465
Reference
  Authors
Esaki N, Enomoto A, Takagishi M, Mizutani Y, Iida T, Ushida K, Shiraki Y, Mii S, Takahashi M
  Title
The Daple-CK1epsilon complex regulates Dvl2 phosphorylation and canonical Wnt signaling.
  Journal
Biochem Biophys Res Commun 532:406-413 (2020)
DOI:10.1016/j.bbrc.2020.08.066
Reference
  Authors
Yiew NKH, Chatterjee TK, Tang YL, Pellenberg R, Stansfield BK, Bagi Z, Fulton DJ, Stepp DW, Chen W, Patel V, Kamath VM, Litwin SE, Hui DY, Rudich SM, Kim HW, Weintraub NL
  Title
A novel role for the Wnt inhibitor APCDD1 in adipocyte differentiation: Implications for diet-induced obesity.
  Journal
J Biol Chem 292:6312-6324 (2017)
DOI:10.1074/jbc.M116.758078
Related
pathway
tpai04010  MAPK signaling pathway
tpai04110  Cell cycle
tpai04115  p53 signaling pathway
tpai04120  Ubiquitin mediated proteolysis
tpai04350  TGF-beta signaling pathway
tpai04510  Focal adhesion
tpai04520  Adherens junction
KO pathway
ko04310   

DBGET integrated database retrieval system